Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Natural interferon-beta in the treatment of relapsing-remitting multiple sclerosis: a multicenter, randomized, MRI-based, phase II clinical trial].
Fernández O, Antigüedad A, Arbizu T, Burgués S, Capdevila A, de Castro P, Correa de Sá JC, García-Merino JA, Izquierdo G, Magalhaes A, Montalbán X, Zarranz JJ. Fernández O, et al. Among authors: izquierdo g. Rev Neurol. 1999 Dec 16-31;29(12):1093-9. Rev Neurol. 1999. PMID: 10652728 Clinical Trial. Spanish.
[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score].
Rio J, Rovira A, Blanco Y, Sainz A, Perkal H, Robles R, Ramio-Torrenta L, Diaz RM, Arroyo R, Urbaneja P, Fernandez O, Garcia-Merino JA, Reyes MP, Oreja-Guevara C, Prieto JM, Izquierdo G, Olascoaga J, Alvarez-Cermeno JC, Simon E, Pujal B, Comabella M, Montalban X. Rio J, et al. Among authors: izquierdo g. Rev Neurol. 2016 Aug 16;63(4):145-50. Rev Neurol. 2016. PMID: 27439483 Free article. Spanish.
[Recommendations for the use of cladribine tablets in recurring multiple sclerosis].
Oreja-Guevara C, García-Merino JA, Saiz A, Rodríguez-Antigüedad A, Álvarez-Cermeño JC, Estrada-Pérez V, Izquierdo G, Fernández O. Oreja-Guevara C, et al. Among authors: izquierdo g. Rev Neurol. 2019 Dec 17;69(s02):1-9. doi: 10.33588/rn.69s02.2019380. Rev Neurol. 2019. PMID: 31933293 Review. Spanish.
[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)].
Fernandez-Fernandez O, Alvarez-Cermeno JC, Arbizu-Urdiain T, Arroyo-Gonzalez R, Arnal-Garcia C, Casanova-Estruch B, Calles-Hernandez MC, Coret-Ferrer F, Comabella M, Garcia-Merino JA, de Las Heras V, Izquierdo G, Meca-Lallana JE, Munoz-Garcia D, Olascoaga J, Oreja-Guevara C, Prieto JM, Rodriguez-Antiguedad A, Tintore M, Montalban X; Grupo Post-ECTRIMS. Fernandez-Fernandez O, et al. Among authors: izquierdo g. Rev Neurol. 2011 Mar 1;52(5):289-99. Rev Neurol. 2011. PMID: 21341224 Free article. Review. Spanish.
Spanish consensus on the use of natalizumab (Tysabri(®))--2011.
Fernández O, García-Merino JA, Arroyo R, Álvarez-Cermeño JC, Arbizu T, Izquierdo G, Saiz A, Olascoaga J, Rodríguez-Antigüedad A, Prieto JM, Oreja-Guevara C, Hernández MA, Montalbán X. Fernández O, et al. Among authors: izquierdo g. Neurologia. 2012 Sep;27(7):432-41. doi: 10.1016/j.nrl.2011.09.008. Epub 2011 Nov 9. Neurologia. 2012. PMID: 22078648 Free article. English, Spanish.
398 results